High endothelial lipase serum concentrations have been observed in T2DM patients [33,34], and angiopoietin-like protein 3 (ANGPTL3), which is an inhibitor of endothelial lipase, is decreased in T2DM patients [60]. This evidence concerns the gene ANGPTL3 and type 2 diabetes mellitus.